Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Pharma&
Pharma&
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Pegasys
Peginterferon alfa-2a
2002-10-16
Renal cell carcinoma
,
Colorectal neoplasms
,
Brain neoplasms
,
Hepatocellular carcinoma
,
Essential thrombocythemia
,
Multiple myeloma
,
Sezary syndrome
,
Skin neoplasms
,
Melanoma
,
Chronic hepatitis c
,
Chronic hepatitis b
,
Hemangioma
,
Thrombocytopenia
,
Macular degeneration
,
Mycosis fungoides
,
Hairy cell leukemia
,
Virus diseases
,
Hepatitis d
,
Respiratory syncytial virus infections
,
Hypereosinophilic syndrome
,
Kaposi sarcoma
,
Warts
,
Skin ulcer
,
Cryoglobulinemia
,
West nile fever
,
Human adenovirus infections
,
Ileal neoplasms
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use